Basal cell carcinoma treated with combined ablative fractional laser and ingenol mebutate — an exploratory study monitored by optical coherence tomography and reflectance confocal microscopy
from Journal of the European Academy of Dermatology and Venereology
Basal cell carcinomas (BCCs) have previously been treated off-label with ingenol mebutate (IM). Ablative fractional laser (AFL) may improve efficacy of IM by increasing drug uptake in the tumor. Optical coherence tomography (OCT) and reflectance confocal microscopy (RCM) detect BCC non-invasively. Our aim was to investigate BCC response and tolerability after combined AFL and IM treatment of low-risk BCCs.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063